Pred17
Pred17 is a potent EGFR inhibitor. Pred17 has the potential for the research of lung cancer[1].
Product Specifications
UNSPSC
12352005
Target
EGFR
Type
Reference compound
Related Pathways
JAK/STAT Signaling; Protein Tyrosine Kinase/RTK
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/pred17.html
Smiles
BrC1=CC=CC(NC2=NC=NC3=C2C=C(C4=CC=CC=C4)C(OC)=C3C5=CC=CC=C5)=C1
Molecular Formula
C27H20BrN3O
Molecular Weight
482.37
References & Citations
[1]Moussaoui M, et al. Design and Optimization of Quinazoline Derivatives as Potent EGFR Inhibitors for Lung Cancer Treatment: A Comprehensive QSAR, ADMET, and Molecular Modeling Investigation. ACS Omega. 2024 Nov 8;9 (46) :45842-45857.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
bs-13394R-BF647 100 µL
Glutaredoxin 2 Polyclonal Antibody, AbBy Fluor™ 647 Conjugated
Sign In for Pricing
View Details